Gene · 667
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into Lichen Planus Pigmentosus Inversus using Minimally Invasive Dermal Patch and Whole Transcriptome Analysis. | J Clin Investig Dermatol | 2022 | 36003415 | PubTator, text mining | PubMed |
| Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants. | J Prim Care Community Health | 2022 | 36000450 | PubTator, text mining | PubMed |
| Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity. | Pathophysiology | 2022 | 35997391 | PubTator, text mining | PubMed |
| Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review. | J Cardiovasc Magn Reson | 2022 | 35989320 | PubTator, text mining | PubMed |
| Integrated multi-omics reveals cellular and molecular interactions governing the invasive niche of basal cell carcinoma. | Nat Commun | 2022 | 35986012 | PubTator, text mining | PubMed |
| RB1 loss triggers dependence on ESRRG in retinoblastoma. | Sci Adv | 2022 | 35984874 | PubTator, text mining | PubMed |
| Local mRNA translation and cytoskeletal reorganization: Mechanisms that tune neuronal responses. | Front Mol Neurosci | 2022 | 35979146 | PubTator, text mining | PubMed |
| Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening. | Front Immunol | 2022 | 35967298 | PubTator, text mining | PubMed |
| Cell Architecture-Dependent Constraints: Critical Safeguards to Carcinogenesis. | Int J Mol Sci | 2022 | 35955754 | PubTator, text mining | PubMed |
| Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression Analysis. | Int J Mol Sci | 2022 | 35955742 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Isoform-specific mutation in Dystonin-b gene causes late-onset protein aggregate myopathy and cardiomyopathy. | Elife | 2022 | 35942699 | PubTator, text mining | PubMed |
| A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma. | Front Immunol | 2022 | 35935986 | PubTator, text mining | PubMed |
| Hypolacrimia and Alacrimia as Diagnostic Features for Genetic or Congenital Conditions. | Invest Ophthalmol Vis Sci | 2022 | 35925585 | PubTator, text mining | PubMed |
| Paraneoplastic Pemphigus Autoantibodies Against C-terminus of Desmoplakin Induced Acantholysis In Vitro and In Vivo. | Front Immunol | 2022 | 35911677 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. | Cell Rep Med | 2022 | 35896115 | PubTator, text mining | PubMed |
| Activation of Oncogenic and Immune-Response Pathways Is Linked to Disease-Specific Survival in Merkel Cell Carcinoma. | Cancers (Basel) | 2022 | 35892849 | PubTator, text mining | PubMed |
| Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid. | Antibodies (Basel) | 2022 | 35892704 | PubTator, text mining | PubMed |
| Desquamative Gingivitis in the Context of Autoimmune Bullous Dermatoses and Lichen Planus-Challenges in the Diagnosis and Treatment. | Diagnostics (Basel) | 2022 | 35885656 | PubTator, text mining | PubMed |
| A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 35884472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/667/papers?page=15